To investigate the efficiency of encapsidation of plasmid by papillomavirus virus-like particles (PV VLPs), and the infectivity of the resultant PV pseudovirions, Cos-1 cells were transfected with an 8-kb plasmid incorporating a green fluorescent protein (GFP) reporter gene (pGSV), and infected with bovine PV (BPV-1) L1/L2 recombinant vaccinia virus to produce BPV1 pseudovirions. Approximately 1 in 1.5x10(4) of dense (1.35 g/ml) PV pseudovirions and 0.3 in 10(4) Of less-dense (1.29 g/ml) pseudovirions packaged an intact pGSV plasmid. The majority (>75%) of packaged plasmids contained deletions, and the deletions affected all tested genes. After exposure of Cos-1 cells to BPV-1 pseudovirions at an MOI of 40,000:1, 6% of cells expressed GFP g...
Human papillomavirus (HPV) L1 and L2 capsid proteins self-assemble into virions capable of efficient...
Human papillomavirus type 18 (HPV18) capsid proteins L1 and L2, synthesised in mammalian cells using...
Non-viral episomal vector systems might allow a safe and reproducible genetic modification of eukary...
Encapsidation of circular DNA by papillomavirus capsid protein was investigated in Cos-1 cells. Plas...
We studied determinants of efficient encapsidation of circular DNA, incorporating a PV early region ...
We have previously described a DNA-packaging assay using bovine papillomavirus type 1 (BPV-1) virus-...
AbstractWe studied determinants of efficient encapsidation of circular DNA, incorporating a PV early...
Papillomavirus capsids are known to have the ability to package DNA plasmids and deliver them both i...
Human papillomavirus (HPV) 16 capsids have been chosen as a DNA delivery vehicle in many studies. Ou...
AbstractWe have previously described a DNA-packaging assay using bovine papillomavirus type 1 (BPV-1...
Papillomavirus capsids are known to have the ability to package DNA plasmids and deliver them both i...
Vaccine efficacy requires the production of neutralising antibodies which offer protection against t...
Bovine papillomavirus type 1 (BPV-1) virions were produced in vitro using vaccinia virus (VV) recomb...
We have examined non-replicative human papillomavirus (HPV) pseudovirions as an approach in the deli...
Human papillomaviruses (HPV) cause cervical cancer and have recently also been implicated in mouth, ...
Human papillomavirus (HPV) L1 and L2 capsid proteins self-assemble into virions capable of efficient...
Human papillomavirus type 18 (HPV18) capsid proteins L1 and L2, synthesised in mammalian cells using...
Non-viral episomal vector systems might allow a safe and reproducible genetic modification of eukary...
Encapsidation of circular DNA by papillomavirus capsid protein was investigated in Cos-1 cells. Plas...
We studied determinants of efficient encapsidation of circular DNA, incorporating a PV early region ...
We have previously described a DNA-packaging assay using bovine papillomavirus type 1 (BPV-1) virus-...
AbstractWe studied determinants of efficient encapsidation of circular DNA, incorporating a PV early...
Papillomavirus capsids are known to have the ability to package DNA plasmids and deliver them both i...
Human papillomavirus (HPV) 16 capsids have been chosen as a DNA delivery vehicle in many studies. Ou...
AbstractWe have previously described a DNA-packaging assay using bovine papillomavirus type 1 (BPV-1...
Papillomavirus capsids are known to have the ability to package DNA plasmids and deliver them both i...
Vaccine efficacy requires the production of neutralising antibodies which offer protection against t...
Bovine papillomavirus type 1 (BPV-1) virions were produced in vitro using vaccinia virus (VV) recomb...
We have examined non-replicative human papillomavirus (HPV) pseudovirions as an approach in the deli...
Human papillomaviruses (HPV) cause cervical cancer and have recently also been implicated in mouth, ...
Human papillomavirus (HPV) L1 and L2 capsid proteins self-assemble into virions capable of efficient...
Human papillomavirus type 18 (HPV18) capsid proteins L1 and L2, synthesised in mammalian cells using...
Non-viral episomal vector systems might allow a safe and reproducible genetic modification of eukary...